• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. SIMON NITINOL FILTER SYSTEM; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. SIMON NITINOL FILTER SYSTEM; VENA CAVA FILTER Back to Search Results
Model Number 2120F
Medical Device Problem Codes Patient-Device Incompatibility (2682); Migration (4003)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 09/16/2011
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Manufacturing review: a manufacturing review was not requested as the lot number reported is unknown.Investigation summary: the device was not returned for evaluation.Medical records were provided and reviewed.Bard simon nitinol filter was deployed in the inferior vena cava, inferior to the renal veins for a patient with pulmonary embolism.An inferior vena cavogram confirmed the appropriate placement of the filter.Approximately, four months and twenty-six days of post-deployment, computed tomography of the chest confirmed no evidence of pulmonary embolism.Around, twenty-two days later, computed tomography of the abdomen was conducted.There was cephalad migration of the apex of the filter which was at or just above the level of the left renal vein.A lateral tilt was noted at 13 degrees, but the apex of the filter did not touch the inferior vena cava wall.Perforation was noted of 2 medial struts of 8 millimeters and 6 millimeters.The top of the strut that perforated by 8 millimeters extended into the lower body of the pancreas.There was a 6-millimeter posterolateral strut perforation.A 2.1-centimeter metallic linear foreign body in the right hepatic lobe was noted, which most likely represented strut migration post-fracture.Therefore, the investigation is confirmed for the perforation of the inferior vena cava (ivc) and filter migration.The definitive root cause could not be determined based upon available information.It is unknown whether patient and/or procedural factors contributed to the event.Labeling review: a review of product labeling documentation (e.G., procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.
 
Event or Problem Description
It was reported through the litigation process that a vena cava filter was placed in a patient with pulmonary embolism.At some time post filter deployment, it was alleged that the filter had perforated and migrated.The device has not been removed and there were no reported attempts made to retrieve the filter.The current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SIMON NITINOL FILTER SYSTEM
Common Device Name
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
MDR Report Key12482245
Report Number2020394-2021-01716
Device Sequence Number14405796
Product Code DTK
UDI-Device Identifier00801741040900
UDI-Public(01)00801741040900
Combination Product (Y/N)N
Initial Reporter StateAZ
Initial Reporter CountryUS
PMA/510(K) Number
K970099
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2011
Reporter Type Manufacturer
Report Source consumer,health professional
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 08/26/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number2120F
Device Catalogue Number2120F
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 08/20/2021
Initial Report FDA Received Date09/16/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
LORAZEPAM, MEPERIDINE, METOPROLOL; PROMETHAZINE, AND WARFARIN
Patient Age60 YR
Patient Weight83
-
-